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Introduction
An estimated 230 million individuals worldwide have 
schistosomiasis1, and more than 90% of  these infections 
occur in Africa2–4. Schistosoma haematobium is the cause of  
urogenital schistosomiasis infections; of  the estimated 43 
million adults in Sub-Saharan Africa who have symptoms 
of  S. haematobium infection, more than 16% have major 
bladder wall pathology5,6. Nearly 75% of  girls and women 
with chronic S. haematobium infection develop female genital 
schistosomiasis (FGS), a condition in which schistosoma 
egg deposition throughout the urogenital tract causes 
granulomas, sandy patches, and rubbery papules on the 
uterus, cervix, and lower genital tract2,7–9. One estimate 
suggests that 19 million girls and women currently infected 
with S. haematobium globally will develop FGS in the next 10 
years2,10. 
In Malawi, chronic infections with schistosomiasis are 
common and contribute to significant morbidity11. The most 
recent national estimate of  the prevalence of  schistosomiasis 
in Malawi was estimated to be between 40% and 50% of  
the population12. However, the National Schistosomiasis 
Control Programme used surveys conducted among high-
risk populations prior to 1991 to calculate this national 
estimate. A more recent survey in 2002 incorporating high- 
and low-risk populations estimated the overall prevalence 
of  S. haematobium among primary school children in Malawi 
to be 6.9%. The prevalence varied substantially by region, 
ranging from 2.0-23.2% for S. haematobium13. 
Obstetric fistula (OF) is a urogynecologic condition that 
is typically a consequence of  prolonged, obstructed labor. 
During obstructed labor, the soft tissues of  the pelvis 
undergo necrosis from lack of  blood supply. This necrosis 
results in an abnormal opening between the vagina and the 
bladder and/or rectum with subsequent incontinence of  
urine and/or feces14. Most of  cases in the developing world 
are vesicovaginal fistulas (VVF)15, which involve an abnormal 
opening between the bladder and the vagina. In Malawi, the 
estimated prevalence of  VVF is 1.6 in 1000 women16.
A few case studies have addressed the relationship between 
schistosomiasis and VVF; however, none specifically detail 
an association between schistosomiasis and OF5,17,18. Given 
that the presence of  S. haematobium in the bladder could lead 
to inflammation, fibrosis, rupture, ulceration, and potentially 
fistula5,19,20, it could also be associated with formation of  OF 
or with delays in healing from VVF repair surgery. Despite 
the biologic plausibility of  S. haematobium contributing to 
OF, a 1970 study by Bland and Gelfand did not find an 
association between urinary schistosomiasis infection and 
OF19. However, this cross-sectional study found a significant 
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Schistosoma haematobium infection has been documented as an uncommon cause of  vesicovaginal fistula (VVF) and can result in impaired 
wound healing of  urogenital tissues. For these reasons, it could potentially be linked to an increased rate of  obstetric fistula among 
women who experience obstructed labor and/or in a higher failure rate of  fistula repair. Therefore, the primary objective of  our study 
was to determine the prevalence of  S. haematobium infection among women undergoing obstetric VVF repair in Lilongwe, Malawi. Our 
secondary objectives were to assess if  S. haematobium infection could be a risk factor for obstetric fistula development or unsuccessful 
VVF repair in our patient population. 
Methods
From July to October 2013, we conducted S. haematobium testing via urine microscopy on 96 patients undergoing obstetric VVF repair 
surgery at the Fistula Care Centre in Lilongwe, Malawi. 
Results
The prevalence of  S. haematobium infection among women undergoing obstetric VVF repair was 2% (n=2). Both women with S. 
haematobium had successful VVF repairs. 
Conclusions
Although S. haematobium has the potential to be a risk factor for obstetric VVF formation or unsuccessful VVF repair, it was uncommon 
among the women in our clinic with obstetric VVF.
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to heal after fistula repair. Treatment or pretesting for 
schistosoma ova in the urine of  patients with VVF and/or 
obstetric fistula could be an important part of  pre-operative 
care in areas endemic for S. haematobium5,17. 
Therefore, the primary objective of  our study was to 
determine the prevalence of  S. haematobium infection among 
women undergoing obstetric VVF repair at a fistula repair 
center in Lilongwe, Malawi. Our secondary objectives were 
to assess if  S. haematobium infection could be a risk factor for 
OF development or unsuccessful VVF repair in our patient 
population. 
Methods
From July to October 2013, urinary schistosomiasis testing 
was conducted on 96 patients who had OF repair surgery 
at the Fistula Care Centre at Bwaila Hospital in Lilongwe, 
Malawi. Most of  the patients at this clinic are from Central 
Malawi, including the lakeshore region. Patients who had 
VVF due to non-obstetric causes were not included in this 
study. 
Women who consented to participate in our study had 
50 mL of  urine collected from their urinary catheter bags 
within 24 hours of  undergoing surgery. The urine specimens 
were immediately delivered to the UNC Project laboratory 
at Bwaila Hospital for urine microscopy to detect the 
presence of S. haematobium ova. Upon arrival in the lab, the 
urine specimen was centrifuged, and then a few drops of  
the sediment were placed on a slide and reviewed under the 
microscope. Microscopy results were documented in the 
patients’ charts, and women who had schistosomiasis were 
treated with praziquantel (40 mg/kg). While pre-operative 
testing for schistosoma ova in the urine of  women with 
VVF has been suggested5,17, we found this suggestion to 
be impractical as our patients had constant leaking of  small 
quantities of  urine, which was not sufficient for collection in 
a urine specimen cup or urinary catheter. 
Nurses and clinicians, fluent in Chichewa, documented 
the following information for all study participants: 
demographics, clinical history, and physical exam information, 
as well as preoperative, operative, and postoperative findings. 
HIV testing was done preoperatively and dye tests were done 
postoperatively (at least 14 days after surgery) to identify 
whether the fistula repair was successful. 
Women were asked to provide written informed consent in 
Chichewa. Participants under the age of  17 completed both 
a Pediatric Assent and Parental Consent Form. The UNC 
School of  Medicine Biomedical Institutional Review Board 
and the Institutional Review Board of  the National Health 
Sciences Research Committee of  Malawi approved the 
consent form and all study materials.
Microscopy results and other study data were entered into 
the REDCap database for the Fistula Care Centre by trained 
research associates21. Stata 12.1 software was used for 
statistical analyses (StataCorp LP, College Station, TX). We 
chose a convenience sample of  up to 100 women who had 
obstetric VVF repair between July and October 2013.
Results
The mean age of  the 96 women included in the study was 
37.7 years (range 17-77) (Table 1). Most women were from 
districts in Central Malawi (78%). All but two women were 
from rural areas, and most were farmers (84%). Most women 
were Christian (90%). 
a Collected at first visit to Fistula Care Centre
b Percentages do not add up to 100% due to rounding 
c Women who live along the border of  Mozambique and Malawi often 
receive health care in Malawi because our hospitals and health centers are 
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Table 1: Baseline characteristics of study participantsa,b
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our OF patient population had a prevalence similar to the 
lower range of  prevalence in the general population of  
Malawi13. Because most of  our patients came from areas 
with a low schistosomiasis prevalence, routine screening 
for S. haematobium in our patient population would not be 
cost-effective given that each test costs USD$4. However, 
screening could be performed and cost-effectively for those 
fistula patients coming to the hospital from areas with a high 
prevalence of  S. haematobium. Further studies to clarify the 
most cost-effective screening approach are warranted.
A study by Bland and Gelfand found the incidence of  S. 
haematobium infection of  the bladder to be no higher in 
obstetric VVF patients than in a control series19. In that study, 
40 (67%) of  60 women in the OF group and 36 (60%) of  60 in 
the control group (women admitted to the gynecologic ward 
without OF) had S. haematobium, which was not a statistically 
significant difference. However, among the 60 women 
undergoing OF repair, they did find a statistically significant 
difference in fistula repair failure. Of  the 40 women with S. 
haematobium, 25 (62.5%) had an unsuccessful fistula repair, 
whereas among the 20 women without S. haematobium, only 6 
(30%) had an unsuccessful fistula repair.
Our study has a few important differences from the Bland 
and Gelfand study19. First, our study did not include control 
subjects, although we did find that the prevalence of  S. 
haematobium among our OF population was similar to the 
prevalence in the general population of  Malawi. Secondly, 
the Bland and Gelfand study was done from 1966 to 1968 in 
an area that is now part of  Zimbabwe and had a much higher 
prevalence for S. haematobium. The high prevalence in that 
study may be due to a lack of  empiric treatment programs 
for schistosomiasis at that time and also due to the fact that 
the authors tested for S. haematobium via urine microscopy, 
rectal snips, and bladder biopsy, whereas we only used 
urine microscopy. Finally, our study differed from theirs in 
postoperative care and evaluation for residual fistula. In the 
Bland and Gelfand study, the urinary catheter was usually left 
in place for 18 days after surgery (catheter removal at 14-21 
days is the standard23, and assessment for residual fistula was 
done by evaluation under anesthesia at that time and again at 
6 weeks after surgery. In contrast, we usually left the urinary 
catheter in place for 14 days and then evaluated for residual 
fistula via dye test immediately after catheter removal. If  the 
dye test is negative and no other medical indications exist for 
hospitalization, then the patient is usually discharged from 
the Fistula Care Centre that day or shortly thereafter. While 
we do ask that our patients return for repeat evaluation for 
residual fistula at the Fistula Care Centre one month after 
surgery, only one of  the two patients who had S. haematobium 
in our study returned for any post-operative evaluation, at 10 
weeks after surgery. She did not have repeat dye testing done 
at that visit but was found to still have a successful fistula 
repair by clinical history and exam.
Given the small and cross-sectional nature of  our study, we 
recognize several limitations. First, most women came from 
areas in Malawi that have a low prevalence of  schistosomiasis 
and this could have influenced our results. Therefore, future 
studies that assess the relationship between obstetric VVF and 
schistosomiasis should comprise more women from areas that 
have a high prevalence of  schistosomiasis. Second, although 
microscopy has been reported to be the most appropriate 
technique for detection of  S. haematobium infection24, S. 
haematobium host egg excretion varies throughout the day and 
The majority of  women had previously sought treatment 
for their leakage (69%); however, only a third of  those who 
sought treatment had prior surgeries to repair their fistulas. 
Most women had little (52%) or no education (44%). 
The prevalence of  S. haematobium infection among women 
with obstetric fistula was 2% (n=2) (Table 2). The two 
patients who tested positive for S. haematobium were both 
from lakeshore areas in Mangochi district. One woman 
was 35 years old and one was 20 years old. Both women 
resided in rural areas, were farmers, and had not completed 
any education. Although both women had previously sought 
treatment for urinary leakage, neither woman had a previous 
operation to repair her fistula. 
The postoperative dye test results for both women 
with schistosomiasis were negative, indicating that their 
repairs were successful. All six women who had positive 
postoperative dye test results (indicating failed fistula repair) 
were schistosomiasis negative. 
Discussion
S. haematobium infection was rare among women undergoing 
surgical repair of  obstetric VVF at our Fistula Care Centre in 
Lilongwe, Malawi. In addition, none of  the women who had a 
failed VVF repair were positive for S. haematobium. Therefore, 
our data do not support the theory that S. haematobium 
infection plays a role in obstetric VVF development or 
unsuccessful VVF repair in Malawi. 
Praziquantel is often given empirically to people in 
communities in Malawi with high rates of  schistosomiasis 
to treat and control schistosomiasis22. The success of  
this program may have contributed to the low prevalence 
of  S. haematobium in our study13. The two women who 
had schistosomiasis were from lakeshore areas with the 
highest rates of S. haematobium infection in Malawi13. 
Although S. haematobium is considered endemic in Malawi, 
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this could challenge the accuracy of  microscopy25. Therefore, 
consecutive urine specimen collection and urine microscopy 
for 2-3 days could improve detection of  S. haematobium. 
Third, we tested for urinary schistosomiasis, not FGS, and 
did not sample the rectum, vagina, or bladder. Perhaps 
damage from an earlier chronic infection or extensive FGS 
is a more meaningful risk factor for VVF. Additionally, we 
tested only for S. haematobium, not S. mansoni, which is less 
common in Malawi. If  S. mansoni causes a pro-inflammatory 
status in the bowel, it could be a risk factor for OF. Ours is 
the only study to evaluate the prevalence of  S. haematobium 
in an obstetric fistula population in the past 45 years and the 
first to evaluate it in Malawi, a country with a relatively high 
rate of  schistosomiasis infection.
Conclusions
Our findings establish that the prevalence of  S. haematobium 
is low among patients in an obstetric fistula center in central 
Malawi and is similar to the prevalence of  S. haematobium 
in the general population of  Malawi. In addition, the two 
patients with S. haematobium had good surgical outcomes, 
and none of  the six women with failed fistula repair were 
positive for S. haematobium. While there remains a plausible 
link between S. haematobium infection and poor healing after 
obstetric fistula surgery with subsequent failure, it was not 
demonstrated in this small cross-sectional study.  
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